In vitro lymphocyte responses to Pseudomonas aeruginosa have been found to be impaired in cystic fibrosis patients with advanced clinical disease. The responses to Klebsiellapneumoniae, Serratia marcescens, and Proteus mirabilis were studied in a similar group of cystic fibrosis patients and normal individuals. Cystic fibrosis patients found to be unresponsive to pseudomonas were also unresponsive to klebsiella, serratia, and proteus. Responsiveness to Staphylococcus aureus was not impaired in cystic fibrosis patients. We postulate that in vitro lymphocyte responses to several gram-negative bacteria require the function of a lymphocyte subpopulation which may be impaired in some cystic fibrosis patients.
The major cause of morbidity and mortality in cystic fibrosis (CF) patients is progressive pulmonary infection with bacterial pathogens, particularly Pseudomonas aeruginosa. Normally, alveolar macrophages and polymorphonuclear cells play an important role in clearing bacteria from the lungs. The phagocytic activity of these cells is enhanced by opsonic humoral factors (immunoglobulins and complement) and by lymphokines released by lymphocytes stimulated by specific antigens (4, 5, 7, 9, 18) . Because of the role played by lymphocytes in the activation of pulmonary macrophages, we have explored the possibility of a specific lymphocyte dysfunction as a mechanism for increased susceptibility to bacterial infection in CF patients. In previous studies, we found that lymphocytes from CF patients with advanced disease were unresponsive in vitro to antibiotic-killed P. aeruginosa used as antigens. Lymphocytes from these same patients had normal proliferative responses to the mitogens phytohemagglutinin and concanavalin A and to antibiotic-killed Staphylococcus aureus, Streptococcus pyogenes, and Haemophilus influenzae (14) . The unresponsiveness to pseudomonas was not dependent on the morphological or serological type of pseudomonas used as antigen and did not vary with the source of the pseudomonas. We now present data indicating that this severe lymphocyte dysfunction also involves other gram-negative bacteria. Bacterial antigen preparations. Bacterial antigens were prepared by using a modification of a previously described method (14) . Well-identified and pure bacterial strains were grown under optimal conditions in Trypticase soy broth without dextrose. Gentamicin was then added to the cultures in a final concentration of 200 jig/ml. The bacteria remaining viable after 2 h were killed by addition of carbenicillin to a final concentration of 4 mg/ml of culture fluid and incubation for 30 min. The antibiotic-killed bacteria were washed by repeated centrifugation with sterile isotonic saline, diluted to a 10% (vol/vol) stock suspension in saline, and stored at 4VC. Before use, the supernatant was discarded, and the bacterial pellet was resuspended to the original concentration in fresh saline; 1, 0.1, 0.01, and 0.001% dilutions were used in lymphocyte culture assays.
MATERIALS AND METHODS

In
Clinical isolates of P. aeruginosa (one classic strain and one mucoid strain), Klebsiella The in vitro lymphocyte responses of controls and CF patients to all bacteria studied are summarized in Table 1 . Background thymidine incorporation and responses to staphylococcus were similar in both groups. Responses to all gram-negative bacteria were lower in CF patients, and these differences were statistically significant for pseudomonas, klebsiella, and serratia. In addition, 40 to 53% of CF patients were nonresponsive (<1,000 net cpm) to pseudomonas, serratia, or klebsiella, whereas only 4 to 17% of the normal controls were nonresponsive to these bacteria (Table 2) . Although CF lymphocyte responses to proteus were lower than l0-8 10-7 10-6 10 5 10-4 10-3 10-2 lo-, (Table 1) , it becomes apparto this bacterium, these differences were not ent that low responsiveness to pseudomonas was statistically significant. associated with low case history scores. In ad-dition, the majority of patients unresponsive to pseudomonas, serratia, klebsiella, and proteus were in the group with low case history scores (Table 2) . Only responses to serratia were significantly lower (P < 0.025) than normal in patients with high case history scores.
In Tables 1 and 2 CF patients are also grouped according to the mean responses of their lymphocytes to two pseudomonas antigens, i.e., responders (>1,000 net cpm) and nonresponders (<1,000 net cpm). Nonresponders to pseudomonas also had lower responses to klebsiella, serratia, and proteus than did responders to pseudomonas ( Table I ). As shown in Table 2 , CF patients unresponsive to pseudomonas generally did not respond to serratia, klebsiella, or proteus, but did respond to staphylococcus. In contrast, the frequency of unresponsiveness to serratia, klebsiella, and proteus was the same in CF patients responsive to pseudomonas and in normal controls (Table 2) .
To determine whether there was a quantitative correlation between responses of lymphocytes to any two of the various gram-negative bacteria studied, correlation coefficients were calculated. No significant correlations were found between these responses in normal individuals and in those CF patients capable of responding to pseudomonas.
Lymphocytes from several CF patients failed to incorporate [3H]thymidine above the unstimulated background rate for all bacterial antigen concentrations tested. In these cases, [3H]thymidine incorporation was even depressed below background. This phenomenon was not seen in 92 tests with normal lymphocytes, but was present in 21 of 96 responses to gram-negative bacteria in CF patients with low case history scores. Viability assessment with trypan blue at the end of the culture period showed no differences between normal cultures with positive stimulation and cultures with thymidine incorporation below background. A typical example is shown in Fig. 1 .
DISCUSSION
In previous studies, lymphocytes from CF patients with low case history scores were found to have decreased or absent tritiated thymidine incorporation when cultured with antibiotickilled P. aeruginosa (14) . In these patients, responses to S. aureus, H. influenzae, and S. pyogenes were the same as for CF patients with high case history scores and normal controls. The present studies extend these observations to include other gram-negative bacteria. CF patients with low case history scores were found to have significantly decreased responses to K. pneumoniae, S. marcescens, and P. mirabilis. In contrast, the frequency of unresponsiveness to pseudomonas, klebsiella, serratia, and proteus was similar in CF patients with high case history scores and normal controls. Patients found to be unresponsive to pseudomonas were also unresponsive to these other gram-negative bacteria. Therefore, defective lymphocyte responses in CF patients with low case history scores are not restricted to pseudomonas but extend to certain other gram-negative bacteria.
The cellular bases of unresponsiveness to pseudomonas and certain other gram-negative bacteria in CF patients with low case history scores are poorly understood at this time. One may think of bacterial cell surfaces as haptencarrier complexes and that lymphocyte responses to bacteria may be analogous to lymphocyte reactions involving hapten-carrier complexes (11) . One lymphocyte subpopulation may be carrier specific, while the other subpopulation is hapten specific; response to the hapten requires normal functioning of both subpopulations. Inability to respond or tolerance to the carrier would also ablate responses to the hapten (19) (20) (21) . In the present system, a common gramnegative antigen may function as the carrier, while each bacterial species has certain unique antigens similar to the haptens. Inability to respond to, or tolerance to, the common gramnegative antigen would be expected to result in loss of responses to species-specific hapten-like antigenic determinants. This may be the situation which exists in CF patients with low case history scores who are unresponsive to pseudomonas, klebsiella, serratia, and proteus. CF patients who have not lost the ability to respond to pseudomonas ( Defective lymphocyte responses to certain gram-negative bacteria appear to be specific for chronically infected CF patients. Non-CF patients with chronic pseudomonas infections have not been found to have a similar defect (15) . However, none of these patients was as seriously ill at the time of study as the CF patients with low case history scores. Immunodeficient patients who became infected with pseudomonas usually also have low responsiveness to staphylococcus and mitogens, reflecting their underlying immune defect (Sorensen and Polmar, unpublished data). Malnutrition, present in some CF patients (nonresponders and responders as well), is frequently associated with T-cell deficiency (1, 3, 10, 12) . CF patients, however, are not lymphopenic and have normal numbers of T-cells (6) and normal lymphocyte responses to phytohemagglutinin and concanavalin A (14, 17) .
CF patients in good clinical condition but with pseudomonas present in their respiratory tract secretions have responses to pseudomonas comparable to noninfected normal individuals (14) . This fact does not necessarily preclude an underlying intrinsic lymphocyte defect since it is difficult to establish what an adequate lymphocyte response should be for these patients. Why patients with a generalized defect in lymphocyte responses to many gram-negative organisms should have an almost specific susceptibility to pseudomonas infection is not clear. It can be postulated that CF patients have a progressive lymphocyte dysfunction which becomes increasingly apparent with advancing clinical disease and that, when this defect is fully expressed, the pseudomonas infection is already so well established that other infections become unlikely.
